Citations (93)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (9)
Joaquín Cartagena-Sevilla, María R. García-Fernández & Juan P. Vicente-Villena. (2016) Analgesic Effect of Botulinum Toxin A in Myofascial Pain Syndrome Patients Previously Treated with Local Infiltration of Anesthetic and Steroids. Journal of Pain & Palliative Care Pharmacotherapy 30:4, pages 269-275.
Read now
Read now
John P Ney & Kevin R Joseph. (2007) Neurologic uses of botulinum neurotoxin type A. Neuropsychiatric Disease and Treatment 3:6, pages 785-798.
Read now
Read now
Giuseppe Brisinda, Federica Cadeddu, Pasquale Mazzeo & Giorgio Maria. (2007) Botulinum toxin A for the treatment of chronic anal fissure. Expert Review of Gastroenterology & Hepatology 1:2, pages 219-228.
Read now
Read now
D. M. Cullen, J. J. W. Boyle, P. L. Silbert, B. J. Singer & K. P. Singer. (2007) Botulinum toxin injection to facilitate rehabilitation of muscle imbalance syndromes in sports medicine. Disability and Rehabilitation 29:23, pages 1832-1839.
Read now
Read now
Sheena Aurora. (2006) Botulinum toxin type A for the treatment of migraine. Expert Opinion on Pharmacotherapy 7:8, pages 1085-1095.
Read now
Read now
Gulnoz S. Dolimbek, Behzod Z. Dolimbek, K. Roger Aoki & M. Zouhair Atassi. (2005) Mapping of the Antibody and T Cell Recognition Profiles of the HN Domain (Residues 449–859) of the Heavy Chain of Botulinum Neurotoxin A in Two High-Responder Mouse Strains. Immunological Investigations 34:2, pages 119-142.
Read now
Read now
Keith A Foster. (2004) The analgesic potential of clostridial neurotoxin derivatives. Expert Opinion on Investigational Drugs 13:11, pages 1437-1443.
Read now
Read now
Markus Naumann & Joseph Jankovic. (2004) Safety of botulinum toxin type A: a systematic review and meta-analysis. Current Medical Research and Opinion 20:7, pages 981-990.
Read now
Read now
Brian Freund & Marvin Schwartz. (2004) Whiplash Associated Disorders. Journal of Whiplash & Related Disorders 3:1, pages 49-58.
Read now
Read now
Articles from other publishers (84)
Gary Borodic. (2023) Botulinum toxin type A in multimodal management of age-related macular degeneration and related diseases. Toxicon 236, pages 107170.
Crossref
Crossref
Carlos Acosta-Olivo, Luis E. Simental-Mendía, Félix Vilchez-Cavazos, Víctor M. Peña-Martínez, Jorge Elizondo-Rodíguez & Mario Simental-Mendía. (2022) Clinical Efficacy of Botulinum Toxin in the Treatment of Plantar Fasciitis: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Archives of Physical Medicine and Rehabilitation 103:2, pages 364-371.e2.
Crossref
Crossref
Dominic Atraszkiewicz. (2021) The processes underlying chronic migraine pathophysiology and its treatment with botulinum toxin type A. Neurology and Clinical Neuroscience 9:6, pages 421-429.
Crossref
Crossref
Edivaldo Miotto, Karina Maria Salvatore Freitas, Aline Akemi Mori, Fabricio Pinelli Valarelli, Ricardo Cesar Gobbi de Oliveira & Renata Cristina Oliveira. (2021) Effect of botulinum toxin on quality of life of patients with chronic myofascial pain. Pain Management 11:5, pages 583-593.
Crossref
Crossref
Hritu Baral, Akiko Sekiguchi, Akihiko Uchiyama, Syahla Nisaa Amalia, Sahori Yamazaki, Yuta Inoue, Yoko Yokoyama, Sachiko Ogino, Ryoko Torii, Mari Hosoi, Ryoko Akai, Takao Iwawaki, Osamu Ishikawa & Sei‐ichiro Motegi. (2021) Inhibition of skin fibrosis in systemic sclerosis by botulinum toxin B via the suppression of oxidative stress. The Journal of Dermatology 48:7, pages 1052-1061.
Crossref
Crossref
Philip Radovic. (2020) Treatment of “plantar fasciitis”/Plantar Heel Pain Syndrome with botulinum toxin — A novel injection paradigm pilot study. The Foot 45, pages 101711.
Crossref
Crossref
Kyung-Hwan Kwon, Kyung Su Shin, Sung Hee Yeon & Dae Gun Kwon. (2019) Application of botulinum toxin in maxillofacial field: Part II. Wrinkle, intraoral ulcer, and cranio-maxillofacial pain. Maxillofacial Plastic and Reconstructive Surgery 41:1.
Crossref
Crossref
Tao WuHai-Xin SongYang Zheng LiYe YeJian-Hua LiXing Yue Hu. (2019) Clinical effectiveness of ultrasound guided subacromial-subdeltoid bursa injection of botulinum toxin type A in hemiplegic shoulder pain. Medicine 98:45, pages e17933.
Crossref
Crossref
Bing-Juin Chiang, Hann-Chorng Kuo & Chun-Hou Liao. (2019) Can Botulinum Toxin A Still Have a Role in Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia Through Inhibition of Chronic Prostatic Inflammation?. Toxins 11:9, pages 547.
Crossref
Crossref
S. Villa, G. Raoul, F. Machuron, J. Ferri & R. Nicot. (2019) Improvement in quality of life after botulinum toxin injection for temporomandibular disorder. Journal of Stomatology, Oral and Maxillofacial Surgery 120:1, pages 2-6.
Crossref
Crossref
Helka M. Heikkilä, Tarja S. Jokinen, Pernilla Syrjä, Jouni Junnila, Anna Hielm-Björkman & Outi Laitinen-Vapaavuori. (2018) Assessing adverse effects of intra-articular botulinum toxin A in healthy Beagle dogs: A placebo-controlled, blinded, randomized trial. PLOS ONE 13:1, pages e0191043.
Crossref
Crossref
Helka M. Heikkilä, Anna K. Hielm-Björkman, John F. Innes & Outi M. Laitinen-Vapaavuori. (2017) The effect of intra-articular botulinum toxin A on substance P, prostaglandin E2, and tumor necrosis factor alpha in the canine osteoarthritic joint. BMC Veterinary Research 13:1.
Crossref
Crossref
Sang Bum HanHyeree Kim, Sang Hyun Cho, Jin Ho ChungHei Sung Kim. (2017) Protective Effect of Botulinum Toxin Type A Against Atopic Dermatitis–Like Skin Lesions in NC/Nga Mice. Dermatologic Surgery 43:3, pages S312-S321.
Crossref
Crossref
Iselin Saltvig & Steen Henrik Matzen. (2017) Incidental Treatment of a Subclinical Chronic Tension-Type Headache by Cosmetic Use of Botulinum Toxin A: A Case Report. Case Reports in Dermatology 9:3, pages 249-253.
Crossref
Crossref
Xiaona Lu, Guocheng Chen, Pengjie Ren, Yan Yang & Fei Fan. (2017) Progress on Botulinum Toxin Type A-Induced Pain Relief in the Field of Plastics. Journal of Craniofacial Surgery 28:8, pages 2045-2052.
Crossref
Crossref
Shehryar N Khawaja. (2017) Botulinum Toxin Type a for the Management of Masticatory Muscle Pain in Temporomandibular Disorders: A Systematic Review. Journal of Dental Health, Oral Disorders & Therapy 7:6.
Crossref
Crossref
Tao Wu, Hai-xin Song, Yan Dong, Ye Ye & Jian-hua Li. (2016) Intra-articular injections of botulinum toxin a for refractory joint pain: a systematic review and meta-analysis. Clinical Rehabilitation 31:4, pages 435-443.
Crossref
Crossref
Jamal Ahmad, Stacy H. Ahmad & Kennis Jones. (2016) Treatment of Plantar Fasciitis With Botulinum Toxin. Foot & Ankle International 38:1, pages 1-7.
Crossref
Crossref
Fatih Asutay, Yusuf Atalay, Hilal Asutay & Ahmet Hüseyin Acar. (2017) The Evaluation of the Clinical Effects of Botulinum Toxin on Nocturnal Bruxism. Pain Research and Management 2017, pages 1-5.
Crossref
Crossref
Tao Wu, Yu Fu, Hai xin Song, Ye Ye, Yan Dong & Jian hua Li. (2015) Effectiveness of Botulinum Toxin for Shoulder Pain Treatment: A Systematic Review and Meta-Analysis. Archives of Physical Medicine and Rehabilitation 96:12, pages 2214-2220.
Crossref
Crossref
Pedro A. Kowacs, Marco A. T. Utiumi, Fábio A. Nascimento, Elcio J. Piovesan & Helio A. G. Teive. (2015) OnabotulinumtoxinA for trigeminal neuralgia: a review of the available data. Arquivos de Neuro-Psiquiatria 73:10, pages 877-884.
Crossref
Crossref
Y.-W. Chen, Y.-W. Chiu, C.-Y. Chen & S.-K. Chuang. (2015) Botulinum toxin therapy for temporomandibular joint disorders: a systematic review of randomized controlled trials. International Journal of Oral and Maxillofacial Surgery 44:8, pages 1018-1026.
Crossref
Crossref
Eman M. I. Moawad & Enas Abdallah Ali Abdallah. (2015) Botulinum Toxin in Pediatric Neurology. Global Pediatric Health 2, pages 2333794X1559014.
Crossref
Crossref
Matthew J. Harries, Sharon Wong & Paul Farrant. (2015) Frontal Fibrosing Alopecia and Increased Scalp Sweating: Is Neurogenic Inflammation the Common Link. Skin Appendage Disorders 1:4, pages 179-184.
Crossref
Crossref
Roshni Ramachandran & Tony L Yaksh. (2014) Therapeutic use of botulinum toxin in migraine: mechanisms of action. British Journal of Pharmacology 171:18, pages 4177-4192.
Crossref
Crossref
Adriana P Soares, Regis B Andriolo, Álvaro N Atallah & Edina MK da Silva. (2014) Botulinum toxin for myofascial pain syndromes in adults. Cochrane Database of Systematic Reviews 2021:6.
Crossref
Crossref
Ki Yeon Yoo, Hee Su Lee, Young Kyung Cho, You Sun Lim, Yi Seul Kim, Jung Hoi Koo, Se Jin Yoon, Jung Hwan Lee, Ki Hyo Jang & Sun Hong Song. (2013) Anti-inflammatory Effects of Botulinum Toxin Type A in a Complete Freund’s Adjuvant-Induced Arthritic Knee Joint of Hind Leg on Rat Model. Neurotoxicity Research 26:1, pages 32-39.
Crossref
Crossref
Andrea L. Nicol, Irene I. Wu & F. Michael Ferrante. (2014) Botulinum Toxin Type A Injections for Cervical and Shoulder Girdle Myofascial Pain Using an Enriched Protocol Design. Anesthesia & Analgesia 118:6, pages 1326-1335.
Crossref
Crossref
Gary E. Borodic, Paul Caruso, Martin Acquadro & Sarah Chick. (2014) Parry-Romberg Syndrome Vasculopathy and Its Treatment With Botulinum Toxin. Ophthalmic Plastic & Reconstructive Surgery 30:1, pages e22-e25.
Crossref
Crossref
Jon Y. Zhou & Dajie Wang. (2013) An Update on Botulinum Toxin A Injections of Trigger Points for Myofascial Pain. Current Pain and Headache Reports 18:1.
Crossref
Crossref
Miia Lindström, Riikka Keto-Timonen & Hannu Korkeala. 2014. Molecular Aspects of Botulinum Neurotoxin. Molecular Aspects of Botulinum Neurotoxin
229
258
.
Gaurav Verma. (2013) Role of Botulinum Toxin Type-A (BTX-A) in the Management of Trigeminal Neuralgia. Pain Research and Treatment 2013, pages 1-6.
Crossref
Crossref
Ryan R. Ramsook & Gerard A. Malanga. (2012) Myofascial Low Back Pain. Current Pain and Headache Reports 16:5, pages 423-432.
Crossref
Crossref
Adriana Soares, Régis B Andriolo, Álvaro N Atallah, Edina MK da Silva & Edina MK da Silva. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Behzod Z. Dolimbek, Lance E. Steward, K. Roger Aoki & M. Zouhair Atassi. (2011) Location of the Synaptosome-Binding Regions on Botulinum Neurotoxin B. Biochemistry 51:1, pages 316-328.
Crossref
Crossref
Thiru Mandyam Annaswamy, Arthur J. De Luigi, Bryan J. O'Neill, Nandita Keole & David Berbrayer. (2011) Emerging Concepts in the Treatment of Myofascial Pain: A Review of Medications, Modalities, and Needle‐based Interventions. PM&R 3:10, pages 940-961.
Crossref
Crossref
M. Zouhair Atassi, Behzod Z. Dolimbek, Joseph Jankovic, Lance E. Steward & K. Roger Aoki. (2011) Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies. Immunobiology 216:7, pages 782-792.
Crossref
Crossref
Tony Zhang, Aleem Adatia, Wasifa Zarin, Misha Moitri, Abi Vijenthira, Rong Chu, Lehana Thabane & Walter Kean. (2010) The efficacy of botulinum toxin type A in managing chronic musculoskeletal pain: a systematic review and meta analysis. Inflammopharmacology 19:1, pages 21-34.
Crossref
Crossref
Gerard A. Malanga & Eduardo J. Cruz Colon. (2010) Myofascial Low Back Pain: A Review. Physical Medicine and Rehabilitation Clinics of North America 21:4, pages 711-724.
Crossref
Crossref
Chen-Liang Chou, Si-Huei Lee, Shin-Yo Lu, Ko-Lun Tsai, Chung-Yu Ho & Hsuan-Chu Lai. (2010) Therapeutic Effects of Intra-articular Botulinum Neurotoxin in Advanced Knee Osteoarthritis. Journal of the Chinese Medical Association 73:11, pages 573-580.
Crossref
Crossref
Gary E. Borodic. (2010) Orbicularis Oculi Myo-osseous Fixation: A New Treatment for Benign Essential Blepharospasm and Blepharospasm Associated With Diffuse Facial Dystonia (Meige Syndrome). Ophthalmic Surgery, Lasers and Imaging Retina 41:3, pages 360-369.
Crossref
Crossref
Jung H. Lee, Sang-Ho Lee & Sun H. Song. (2010) Clinical Effectiveness of Botulinum Toxin A Compared to a Mixture of Steroid and Local Anesthetics as a Treatment for Sacroiliac Joint Pain. Pain Medicine 11:5, pages 692-700.
Crossref
Crossref
Andrea J. Boon, Jay Smith, Diane L. Dahm, Eric J. Sorenson, Dirk R. Larson, Patrick D. Fitz‐Gibbon, Dennis D. Dykstra & Jasvinder A. Singh. (2010) Efficacy of Intra‐Articular Botulinum Toxin Type A in Painful Knee Osteoarthritis: A Pilot Study. PM&R 2:4, pages 268-276.
Crossref
Crossref
Juan Pérez Cajaraville, David Abejón González, Rosana Sainz Camuñas & José Ramón Ortiz Gómez. 2010. Toxina Botulínica. Toxina Botulínica
267
299
.
Clifford Gevirtz. (2009) CME ARTICLE. Topics in Pain Management 25:3, pages 1-5.
Crossref
Crossref
M. Zouhair Atassi. (2009) Immune recognition of BoNTs A and B: How anti-toxin antibodies that bind to the heavy chain obstruct toxin action. Toxicon 54:5, pages 600-613.
Crossref
Crossref
Parisa Gazerani. 2009. Peripheral Receptor Targets for Analgesia. Peripheral Receptor Targets for Analgesia
297
324
.
Adriana Soares, Régis B Andriolo, Álvaro N Atallah & Edina MK da Silva. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Jun-Suk Kang, Karsten Krakow, Julia Roggendorf, Helmuth Steinmetz & Ruediger Hilker. (2009) Botulinum toxin treatment of epilepsia partialis continua. Movement Disorders 24:1, pages 141-143.
Crossref
Crossref
M. Zouhair Atassi & K. Roger Aoki. 2009. Botulinum Toxin. Botulinum Toxin
53
76.e8
.
Leonidas Manolopoulos, Petros V. Vlastarakos, Lucas Georgiou, Ioannis Giotakis, Anthony Loizos & Thomas P. Nikolopoulos. (2008) Myofascial pain syndromes in the maxillofacial area: a common but underdiagnosed cause of head and neck pain. International Journal of Oral and Maxillofacial Surgery 37:11, pages 975-984.
Crossref
Crossref
Behzod Z. Dolimbek, Lance E. Steward, K. Roger Aoki & M. Zouhair Atassi. (2008) Immune recognition of botulinum neurotoxin B: Antibody-binding regions on the heavy chain of the toxin. Molecular Immunology 45:4, pages 910-924.
Crossref
Crossref
Roberto Casale & Valeria Tugnoli. (2008) Botulinum Toxin for Pain. Drugs in R & D 9:1, pages 11-27.
Crossref
Crossref
A. Kemal Erdemoglu & Ayhan Varlibas. (2007) The long-term efficacy and safety of botulinum toxin in refractory chronic tension-type headache. The Journal of Headache and Pain 8:5, pages 294-300.
Crossref
Crossref
Valeria Tugnoli, Jay Guido Capone, Roberto Eleopra, Rocco Quatrale, Mariachiara Sensi, Ernesto Gastaldo, Maria Rosaria Tola & Pierangelo Geppetti. (2007) Botulinum Toxin type A reduces capsaicin-evoked pain and neurogenic vasodilatation in human skin. Pain 130:1, pages 76-83.
Crossref
Crossref
Ramesh R. Kale, Colin M. Clancy, Rebecca M. Vermillion, Eric A. Johnson & Suri S. Iyer. (2007) Synthesis of soluble multivalent glycoconjugates that target the Hc region of botulinum neurotoxin A. Bioorganic & Medicinal Chemistry Letters 17:9, pages 2459-2464.
Crossref
Crossref
M. Zouhair Atassi, Behzod Z. Dolimbek, Philip Deitiker, Joseph Jankovic & K. Roger Aoki. (2006) A peptide‐based immunoassay for antibodies against botulinum neurotoxin A. Journal of Molecular Recognition 20:1, pages 15-21.
Crossref
Crossref
Guy Monnier, Laurent Tatu & Fabrice Michel. (2006) Les indications de la toxine botulinique en rhumatologie. Revue du Rhumatisme 73:12, pages 1331-1337.
Crossref
Crossref
Guy Monnier, Laurent Tatu & Fabrice Michel. (2006) New indications for botulinum toxin in rheumatology. Joint Bone Spine 73:6, pages 667-671.
Crossref
Crossref
Arthur H. Elkind, Philip O’Carroll, Andrew Blumenfeld, Ronald DeGryse & Rozalina Dimitrova. (2006) A Series of Three Sequential, Randomized, Controlled Studies of Repeated Treatments With Botulinum Toxin Type A for Migraine Prophylaxis. The Journal of Pain 7:10, pages 688-696.
Crossref
Crossref
Brian Freund & Marvin Schwartz. (2006) The role of botulinum toxin in whiplash injuries. Current Pain and Headache Reports 10:5, pages 355-359.
Crossref
Crossref
E. QeramaA. Fuglsang-FrederiksenH. KaschF. W. BachT. S. Jensen. (2006) A double-blind, controlled study of botulinum toxin A in chronic myofascial pain. Neurology 67:2, pages 241-245.
Crossref
Crossref
M. Zouhair Atassi. (2006) On the enhancement of anti-neurotoxin antibody production by subcomponents HA1 and HA3b of Clostridium botulinum type B 16S toxin-haemagglutinin. Microbiology 152:7, pages 1891-1895.
Crossref
Crossref
John P. Ney, Marc Difazio, Afsoun Sichani, William Monacci, Leslie Foster & Bahman Jabbari. (2006) Treatment of Chronic Low Back Pain With Successive Injections of Botulinum Toxin A Over 6 Months. The Clinical Journal of Pain 22:4, pages 363-369.
Crossref
Crossref
Takahiro Maruta, Behzod Z. Dolimbek, K. Roger Aoki & M. Zouhair Atassi. (2006) Inhibition by human sera of botulinum neurotoxin-A binding to synaptosomes: A new assay for blocking and non-blocking antibodies. Journal of Neuroscience Methods 151:2, pages 90-96.
Crossref
Crossref
Norah S. Lincoff. (2006) Treatment of chronic facial pain. Current Treatment Options in Neurology 8:1, pages 69-79.
Crossref
Crossref
Eric A. Johnson, Gary E. Borodic & Martin A. Acquadro. 2006. The Comprehensive Sourcebook of Bacterial Protein Toxins. The Comprehensive Sourcebook of Bacterial Protein Toxins
959
975
.
F Michael Ferrante, Lisa Bearn, Robert Rothrock & Laurence King. (2005) Evidence against Trigger Point Injection Technique for the Treatment of Cervicothoracic Myofascial Pain with Botulinum Toxin Type A. Anesthesiology 103:2, pages 377-383.
Crossref
Crossref
Hiroki Iida, Kazuyuki Sumi, Motoyasu Takenaka, Toshio Asano, Shigemi Matsumoto, Toru Iwama & Shuji Dohi. (2005) Periorbital pain associated with hemifacial spasms that responded to botulinum toxin treatment and microvascular decompression surgery: a case report. Journal of Clinical Anesthesia 17:5, pages 363-365.
Crossref
Crossref
Noor M. Gajraj. (2005) Botulinum Toxin a Injection of the Obturator Internus Muscle for Chronic Perineal Pain. The Journal of Pain 6:5, pages 333-337.
Crossref
Crossref
Keith A. Foster. (2005) A new wrinkle on pain relief: re-engineering clostridial neurotoxins for analgesics. Drug Discovery Today 10:8, pages 563-569.
Crossref
Crossref
K. Görlinger, H. Göbel, V.M. Tronnier, A. Rolf, U. Thoden, D. E. Rosenow, C. Zimmer, R. Mattmüller & R. Becker. 2005. Neurogener Schmerz. Neurogener Schmerz
289
355
.
Min Dong, William H. Tepp, Eric A. Johnson & Edwin R. Chapman. (2004)
Using fluorescent sensors to detect botulinum neurotoxin activity
in vitro
and in living cells
. Proceedings of the National Academy of Sciences 101:41, pages 14701-14706.
Crossref
Crossref
Steven P. Cohen, Rohan Mullings & Salahadin Abdi. (2004) The Pharmacologic Treatment of Muscle Pain. Anesthesiology 101:2, pages 495-526.
Crossref
Crossref
Avi AshkenaziStephen D. Silberstein. (2004) Botulinum Toxin and Other New Approaches to Migraine Therapy. Annual Review of Medicine 55:1, pages 505-518.
Crossref
Crossref
Paolo Martelletti & Hans van Suijlekom. (2004) Cervicogenic Headache. CNS Drugs 18:12, pages 793-805.
Crossref
Crossref
Paul L. Durham, Ryan Cady & Roger Cady. (2004) Regulation of Calcitonin Gene‐Related Peptide Secretion From Trigeminal Nerve Cells by Botulinum Toxin Type A: Implications for Migraine Therapy. Headache: The Journal of Head and Face Pain 44:1, pages 35-43.
Crossref
Crossref
Mike A. Royal. (2003) Botulinum toxins in pain management. Physical Medicine and Rehabilitation Clinics of North America 14:4, pages 805-820.
Crossref
Crossref
Amy M. Lang. (2003) A preliminary comparison of the efficacy and tolerability of botulinum toxin serotypes A and B in the treatment of myofascial pain syndrome: A retrospective, open-label chart review. Clinical Therapeutics 25:8, pages 2268-2278.
Crossref
Crossref
Howard S. Smith, Joseph Audette & Mike A. Royal. (2002) Botulinum Toxin in Pain Management of Soft Tissue Syndromes. The Clinical Journal of Pain 18:Supplement, pages S147-S154.
Crossref
Crossref
Joseph C. Arezzo. (2002) Possible Mechanisms for the Effects of Botulinum Toxin on Pain. The Clinical Journal of Pain 18:Supplement, pages S125-S132.
Crossref
Crossref
Brian J. Freund & Marvin Schwartz. (2002) Relief of Tension‐type Headache Symptoms in Subjects with Temporomandibular Disorders Treated with Botulinum Toxin‐A. Headache: The Journal of Head and Face Pain 42:10, pages 1033-1037.
Crossref
Crossref
Geoffrey Sheean. (2002) Botulinum toxin for the treatment of musculoskeletal pain and spasm. Current Pain and Headache Reports 6:6, pages 460-469.
Crossref
Crossref
Gary E. Borodic & Martin A. Acquadro. (2002) The use of botulinum toxin for the treatment of chronic facial pain. The Journal of Pain 3:1, pages 21-27.
Crossref
Crossref